WP
IDXX icon

Waycross Partners’s Idexx Laboratories IDXX Stock Holding History

Waycross Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-43,471
Closed -$27.8M – 96
2025
Q3 		$27.8M Buy
43,471
+961
+2% +$583K 2.39% 18
2025
Q2 		$22.8M Buy
42,510
+1,557
+4% +$745K 2.15% 22
2025
Q1 		$17.2M Buy
40,953
+8,515
+26% +$3.7M 1.93% 26
2024
Q4 		$13.4M Buy
+32,438
New +$14.2M 1.74% 27

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

Waycross Partners's IDXX Position: Q4 2025 in Review

Waycross Partners sold out of Idexx Laboratories (IDXX) in Q4 2025, closing a stake of 43,471 shares — an estimated $27.8M sold.

Waycross Partners first reported a position in IDXX in Q4 2024 and held it in 4 quarters. The position peaked at $27.8M in Q3 2025. 1,386 funds tracked by Wall St. Rank hold IDXX as of Q4 2025.

  • Waycross Partners reported no remaining Idexx Laboratories position as of Q4 2025 after selling out during the quarter.
  • Waycross Partners sold 43,471 Idexx Laboratories shares in Q4 2025, an estimated $27.8M.
  • Waycross Partners first reported a position in Idexx Laboratories in Q4 2024 and held it in 4 quarters.
  • Waycross Partners's Idexx Laboratories position peaked at $27.8M in Q3 2025.
  • 1,386 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2025.

Based on Waycross Partners's 13F filing for Q4 2025, filed 14 Jan 2026.